Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker ...
President Biden’s single term in office will be marked by several moments that saw the White House take the spotlight. It ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
Biden’s domestic policy adviser says Trump avoided pledges to overhaul the Affordable Care Act and other health programs — ...
the White House announced Wednesday, a 9% jump from the prior year, with a week left for more to enroll. The 2025 ...
Biden spent like no president in history, and, with a sleight of hand, by taking hundreds of billions out of Medicare and ...
Nearly 24 million Americans enrolled in the Affordable Care Act for 2025, a record-breaking total. The White House said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback